Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: Potential application to melanoma
- 6 August 2007
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 18 (5-6) , 491-501
- https://doi.org/10.1016/j.cytogfr.2007.06.022
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Estrogen Receptor-α Methylation Predicts Melanoma ProgressionCancer Research, 2006
- Contribution of interferon‐β to the immune activation induced by double‐stranded DNAImmunology, 2006
- A critical function for type I interferons in cancer immunoeditingNature Immunology, 2005
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Differential involvement of IFN- in Toll-like receptor-stimulated dendritic cell activationInternational Immunology, 2002
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Shared receptor components but distinct complexes for α and β interferonsJournal of Molecular Biology, 1998
- Deletions of Interferon Genes in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1990